Mayo Clinic Minute: How is kidney cancer treated?
More than 50,000 people in the U.S. are diagnosed with kidney cancer each year. Risks factors for developing this type of cancer include environmental exposures, such as smoking, high blood pressure, a history of kidney failure, obesity or not having a healthy weight. And there are also hereditary syndromes that may increase your risk for kidney cancer. Dr. Thai Ho, a Mayo Clinic oncologist who specializes in genitourinary malignancies, says there are no screening tests… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - March 20, 2023 Category: Databases & Libraries Source Type: news
Telix gets FDA nod for gallium injection prep kit
The U.S. Food and Drug Administration (FDA) has cleared Telix Pharmaceuticals...Read more on AuntMinnie.comRelated Reading:
Telix makes two new executive appointments
Telix highlights kidney cancer imaging study results
Telix relocates U.S. headquarters
Telix obtains Health Canada clearance for Illuccix
Telix highlights EANM presentations (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 16, 2023 Category: Radiology Source Type: news
The Challenge of Removing Toxic PFAS ‘Forever Chemicals’ from Drinking Water
What’s in your faucet can be a dangerous thing. If you’re like an estimated 200 million Americans, every time you turn on the tap, a host of contaminants come out with the water. Among these are trace amounts of PFAS, short for per- and polyfluoroalkyl substances. Also known as “forever chemicals”—because that’s pretty much how long they linger in the environment—exposure to these ubiquitous manufacturing chemicals have been linked by the U.S. Environmental Protection Agency (EPA) to potential health consequences including decreased fertility, hypertension in pregnant people, incre...
Source: TIME: Health - March 15, 2023 Category: Consumer Health News Authors: Jeffrey Kluger Tags: Uncategorized Environmental Health healthscienceclimate Source Type: news
EPA To Crack Down on Toxic PFAS ‘ Forever Chemicals ’ in Drinking Water
The Environmental Protection Agency on Tuesday proposed limiting the amount of harmful “forever chemicals” in drinking water to the lowest level that tests can detect, a long-awaited protection the agency said will save thousands of lives and prevent serious illnesses, including cancer.
The plan marks the first time the EPA has proposed regulating a toxic group of compounds that are widespread, dangerous and expensive to remove from water. PFAS, or per- and polyfluorinated substances, don’t degrade in the environment and are linked to a broad range of health issues, including low birthweight babies and ki...
Source: TIME: Science - March 14, 2023 Category: Science Authors: MICHAEL PHILLIS and MATTHEW DALY / AP Tags: Uncategorized Environmental Health healthscienceclimate wire Source Type: news
Novel PET Imaging Agent Accurately IDs Clear Cell Renal Cancers
(MedPage Today) -- An investigational PET imaging agent -- zirconium-89 (89Zr)-deferoxamine (DFO)-girentuximab -- identified clear cell renal cell carcinoma (ccRCC) with high sensitivity and specificity, according to results from the phase... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 13, 2023 Category: Hematology Source Type: news
Benefits Persist for Lenvatinib, Pembrolizumab in Renal Cell Cancer
MONDAY, March 13, 2023 -- For patients with advanced renal cell carcinoma, progression-free survival and overall survival are improved with lenvatinib plus pembrolizumab versus sunitinib, according to a study published in the March issue of The... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 13, 2023 Category: Pharmaceuticals Source Type: news
Key Abstracts in Renal Cell Carcinoma From ASCO GU 2023 Key Abstracts in Renal Cell Carcinoma From ASCO GU 2023
Key data in renal cell carcinoma from ASCO GU 2023 include phase 3 results on girentuximab and updates of CheckMate 9ER and COSMIC-313, which examined combination therapies in the frontline setting.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 10, 2023 Category: Consumer Health News Tags: None ReCAP Source Type: news
SPECT/CT superior to SPECT alone for imaging cardiac amyloidosis
SPECT/CT fusion imaging offers significant advantages over SPECT alone for imagin...Read more on AuntMinnie.comRelated Reading:
Fast acquisition techniques cut SPECT/CT bone scan times by half
SPECT/CT AI model predicts major adverse cardiac events
SPECT tracers go head-to-head in prostate cancer patients
SPECT/CT proves value over CT diagnosing renal cancer
Tc-99m SPECT/CT imaging detects COVID-19 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 10, 2023 Category: Radiology Source Type: news
New BAP1 Finding Could Be Key to Regulating Mesothelioma
Mesothelioma is a rare cancer most often caused by exposure to asbestos fibers. Our researchers at the University of Hawaii Cancer Center have discovered how asbestos causes mesothelioma, which we linked mainly to the protein HMGB1.
After several years of studying a unique mesothelioma epidemic in Cappadocia, Turkey, we noted that in certain families, up to 50% of family members developed mesothelioma. We demonstrated that susceptibility to mesothelioma was transmitted genetically from one generation to the next.
Following this discovery, several U.S. families with multiple mesothelioma cases contacted us...
Source: Asbestos and Mesothelioma News - March 9, 2023 Category: Environmental Health Authors: Fran Mannino Tags: Clinical Trials/Research/Emerging Treatments Mesothelioma Source Type: news
Taking a Break From TKIs Unlikely to Shorten Survival Taking a Break From TKIs Unlikely to Shorten Survival
A unique study in patients with renal cell carcinoma on tyrosine kinase inhibitors (TKIs) shows that taking a break from the drugs is feasible and cost-effective.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 7, 2023 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Genomic Sequencing Predicts Risk of Kidney Cancer Relapse Genomic Sequencing Predicts Risk of Kidney Cancer Relapse
Twelve genetic mutations in clear-cell renal cell carcinoma may predict which patients will experience recurrence; they could also help personalize adjuvant treatment, researchers say.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 7, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Long-Term Benefit From Nivolumab Plus Cabozantinib in RCC Long-Term Benefit From Nivolumab Plus Cabozantinib in RCC
First-line nivolumab plus cabozantinib continues to show superiority to sunitinib in the treatment of patients with advanced advanced renal cell carcinoma (RCC).Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 3, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Mutational Signature Indicates Risk of Kidney Cancer Recurrence
DNA sequencing can identify mutations that predict recurrence of renal cell carcinoma and may help low-risk patients avoid unnecessary treatment, a study finds. (Source: The Scientist)
Source: The Scientist - March 1, 2023 Category: Science Tags: News & Opinion Source Type: news
Combo Falters in Papillary Renal Cancer, but Some Promise in MET-Driven Subset
(MedPage Today) -- Treatment with an investigational MET inhibitor plus a PD-L1 inhibitor induced responses in fewer than a third of patients with metastatic papillary renal cancer, but the combination showed promise for one subgroup, findings... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - February 24, 2023 Category: Hematology Source Type: news
Research finds DNA mutations could predict kidney cancer outcomes
Doctors may be able to predict the outlook for patients suffering from certain forms of kidney cancer based on looking at DNA mutations, according to new research published Thursday. (Source: Health News - UPI.com)
Source: Health News - UPI.com - February 24, 2023 Category: Consumer Health News Source Type: news
